These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 12601346

  • 1. HCC surveillance: who is the target population?
    Bruix J, Llovet JM.
    Hepatology; 2003 Mar; 37(3):507-9. PubMed ID: 12601346
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR, Marrero JA.
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [Abstract] [Full Text] [Related]

  • 5. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 6. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Velázquez RF, Rodríguez M, Navascués CA, Linares A, Pérez R, Sotorríos NG, Martínez I, Rodrigo L.
    Hepatology; 2003 Mar; 37(3):520-7. PubMed ID: 12601348
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, Nagaoka S, Akiyoshi J, Inoue K, Torimura T, Kumashiro R, Ueno T, Sata M.
    J Clin Gastroenterol; 2006 Mar; 40(10):942-8. PubMed ID: 17063116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
    Kuo YH, Lu SN, Chen CL, Cheng YF, Lin CY, Hung CH, Chen CH, Changchien CS, Hsu HC, Hu TH, Lee CM, Wang JH.
    Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G, Llovet JM.
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract] [Full Text] [Related]

  • 15. [Mass screening for high risk group of hepatocellular carcinoma].
    Kawanishi T, Mima S.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():786-90. PubMed ID: 11762057
    [No Abstract] [Full Text] [Related]

  • 16. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, Tung HD, Chen TM, Huang WS, Lee CM, Chen CC, Changchien CS.
    Cancer; 2006 Nov 01; 107(9):2212-22. PubMed ID: 17019738
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA, London WT.
    Best Pract Res Clin Gastroenterol; 2005 Feb 01; 19(1):3-23. PubMed ID: 15757802
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [High risk group and screening methods of hepatocellular carcinoma].
    Matsushita E, Kaneko S, Kobayashi K.
    Nihon Rinsho; 2001 Oct 01; 59 Suppl 6():229-35. PubMed ID: 11761945
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.